Cargando…
What can we do about patients presenting with myeloma and severe renal failure? Observations from the UK MERIT plasma exchange trial
Myeloma patients presenting with renal failure continue to have a poor prognosis despite significant advances in anti‐myeloma therapy. MERIT was a randomised clinical trial (RCT), set up to evaluate if mechanical reduction of elevated free light chain levels (FLC) would result in clinical benefit. C...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928667/ https://www.ncbi.nlm.nih.gov/pubmed/36819186 http://dx.doi.org/10.1002/jha2.620 |